Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Loading…
Loading…
Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study
Shuvy, Mony, Bardeleben, Ralph Stephan, Grasso, Carmelo, Raake, Philip, Lurz, Philipp, Zamorano, Jose L., Asch, Federico, Kar, Saibal, Maisano, Francesco
Published in ESC Heart Failure (01.04.2023)
Published in ESC Heart Failure (01.04.2023)
Get full text
Journal Article
Loading…
Loading…
Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?
Roul, Gerald, Germain, Philippe, Bareiss, Pierre
Published in The American heart journal (01.09.1998)
Published in The American heart journal (01.09.1998)
Get full text
Journal Article
Loading…
Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients
Godard, Michael, Song, Delafontaine, Whitman
Published in Clinical interventions in aging (01.01.2012)
Published in Clinical interventions in aging (01.01.2012)
Get full text
Journal Article
Loading…
Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome
Palazzuoli, Alberto, Quatrini, Ilaria, Calabrò, Anna, Antonelli, Giovanni, Caputo, Maria, Campagna, Maria S., Franci, Beatrice, Nuti, Ranuccio
Published in Clinical and experimental medicine (01.03.2011)
Published in Clinical and experimental medicine (01.03.2011)
Get full text
Journal Article
Loading…
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design
Zile, Michael, Gaasch, William, Little, William, Francis, Gary, Tavazzi, Luigi, Cleland, John, Davies, Martin
Published in Journal of cardiac failure (01.06.2004)
Published in Journal of cardiac failure (01.06.2004)
Get full text
Journal Article
Loading…
Frequency of Transition of patients with NYHA class III / IV to NYHA class I / II / III of stage C and D Heart Failure with Pharmacotherapy in a Tertiary Level Hospital
Ansari, Sanjida, Kabir, Md Faisal Ibn, Ahmed, Khurshed, Ahsan, Syed Ali, Ahmed, Chaudhary Meskat, Khaled, Md Fakhrul Islam, Siraj, Mausool, Nahar, Jannatun, Biswas, Sumon Kumar, Karna, Rajan, Ahsan, Mohammad Hashimul, Islam, Rashedul, Hoque, Md Harisul
Published in University heart journal (31.01.2022)
Published in University heart journal (31.01.2022)
Get full text
Journal Article
Loading…
Yoga as an adjuvant therapy in heart failure patients on optimal medical management analysed using echocardiographic parameters
Prabhu, Sridevi, Annapoorna, K., Devasia, Tom, Paramasivam, Ganesh, Nayak, Krishnananda, shetty, Lavya, Singh, Ajit, Samanth, Jyothi
Published in Explore (New York, N.Y.) (01.09.2023)
Published in Explore (New York, N.Y.) (01.09.2023)
Get full text
Journal Article
Loading…
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification
Providência, Rui, Boveda, Serge, Defaye, Pascal, Segal, Oliver, Algalarrondo, Vincent, Sadoul, Nicolas, Lambiase, Pier, Piot, Olivier, Klug, Didier, Perier, Marie-Cecile, Bouzeman, Abdeslam, Barra, Sergio, Bories, Marie-Cécile, Gras, Daniel, Fauchier, Laurent, Bordachar, Pierre, Babuty, Dominique, Deharo, Jean-Claude, Leclercq, Christophe, Marijon, Eloi
Published in The American journal of cardiology (15.10.2016)
Published in The American journal of cardiology (15.10.2016)
Get full text
Journal Article
Loading…
Loading…
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure
Lee, Shang-Chiun, Stevens, Tracy L., Sandberg, Sharon M., Heublein, Denise M., Nelson, Susan M., Jougasaki, Michihisa, Redfield, Margaret M., Burnett, John C.
Published in Journal of cardiac failure (01.06.2002)
Published in Journal of cardiac failure (01.06.2002)
Get full text
Journal Article
Loading…
Clinical Trial: A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of NAN-101 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy
Published in US Fed News Service, Including US State News
(29.10.2022)
Get full text
Newsletter
Loading…
Loading…
Heart rate variability in heart failure
Musialik-Łydka, Agata, Sredniawa, Beata, Pasyk, Stanisław
Published in Kardiologia polska (1957) (01.01.2003)
Get full text
Published in Kardiologia polska (1957) (01.01.2003)
Journal Article
Loading…
Dr. James Young Appointed Principal Investigator for Vasogen's Confirmatory Study in NYHA Class II Heart Failure
Published in Canada NewsWire
(19.09.2007)
Get full text
Newsletter
Loading…
Cardiac contractility modulation improves long‐term survival and hospitalizations in heart failure with reduced ejection fraction
Anker, Stefan D., Borggrefe, Martin, Neuser, Hans, Ohlow, Marc‐Alexander, Röger, Susanne, Goette, Andreas, Remppis, Bjoern A., Kuck, Karl‐Heinz, Najarian, Kevin B., Gutterman, David D., Rousso, Benny, Burkhoff, Daniel, Hasenfuss, Gerd
Published in European journal of heart failure (01.09.2019)
Published in European journal of heart failure (01.09.2019)
Get full text
Journal Article
Loading…